Ingrid Licht
Edmonton, Alberta
A non-invasive treatment for macular degeneration
Explore MacuMira treatment in British Columbia
If dry age-related macular degeneration is making it harder to read, recognize faces, or enjoy daily life, MacuMira is a non-invasive treatment option designed to improve visual function.
Fill out the form below to learn more about MacuMira treatment options.
If the form does not load, please refresh this page and try again.
Patient experiences
Watch Ingrid, Edith, and Frances share their experiences with MacuMira treatment for dry age-related macular degeneration.
Edmonton, Alberta
Edmonton, Alberta
Fergus, Ontario
Individual experiences and treatment results may vary.
For people living with dry age-related macular degeneration
Many people with dry age-related macular degeneration are told to monitor their vision and wait. MacuMira offers a different path: a non-invasive treatment intended to improve visual function.
MacuMira uses gentle microcurrent stimulation delivered over closed eyelids in clinic. There are no injections, no incisions, and no recovery time.
Ask about your options →What to expect
MacuMira treatment takes place in a comfortable clinic environment. It is intended for people diagnosed with dry age-related macular degeneration. An eye care professional will review your diagnosis, vision and eye health to determine whether treatment is suitable for you.
Discuss your dry age-related macular degeneration diagnosis, your vision concerns, and whether MacuMira may be appropriate for you.
The initial course includes four sessions over approximately 2 weeks.
Ongoing maintenance is typically one session every three months when appropriate.
Frequently asked questions
Have questions? Request a consultation to learn about your options.
Request a consultation →MacuMira is designed for people with dry age-related macular degeneration. Your eye care professional will review your diagnosis, vision and eye health to determine whether this treatment is suitable for you.
Treatment is non-invasive, with no injections or surgery. MacuMira uses a specialized headset to deliver gentle microcurrent stimulation in a comfortable clinic environment. Your provider can explain what to expect during treatment.
Based on clinical studies and real-world experience, many patients who experience improvement notice changes during the four initial treatments in the first 2 weeks. Maintenance treatments are intended to help maintain those improvements. Individual results vary, and improvement is not guaranteed.
Each session takes approximately 32 minutes. Treatment typically begins with four sessions over about 2 weeks, followed by maintenance visits approximately every three months when appropriate.
MacuMira is a treatment intended to improve visual function in people with dry age-related macular degeneration. It is not a cure, and individual outcomes vary.
Treatment costs can be discussed during your consultation.
Take the next step
Have dry age-related macular degeneration or been told you have limited treatment options? Request a consultation to discuss whether MacuMira may be suitable for you.
Submit the form to learn more about MacuMira treatment options.
If the form does not load, please refresh this page and try again.